Literature DB >> 6508406

The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma.

J W Kelly, R W Sagebiel, W Calderon, L Murillo, R L Dakin, M S Blois.   

Abstract

A retrospective study was undertaken of local, regional, and distant recurrences in 346 patients with primary melanomas of tumor thickness less than 1.0 mm that were excised with margins of normal skin varying between 0.1 cm and 5.0 cm or more. Prospective histopathologic examination of 284 melanomas for the presence of microsatellites was also performed and their effect upon the frequency of local recurrence was studied. Margins of excision did not influence the frequency of local, regional, or distant metastases. Four recurrences of in situ superficial spreading melanoma occurred, however, when very narrow margins of excision (0.5 cm or less) were employed. Microsatellites were uncommon with tumors less than 3.0 mm in thickness (2.8% of all tumors of less than 3.0 mm in thickness, taken together), but relatively frequent in association with thicker tumors (37%). Melanomas with microsatellites were associated with a greater frequency of local clinical metastasis than those without (14% vs. 3%). Removal of more than 1.0 cm of normal skin around a melanoma of less than 1.0 mm in thickness does not further reduce rates of recurrence of any type. The use of margins of 0.5 cm or less for melanomas with a radial growth phase does appear to result in an increased frequency of local recurrence of the primary melanoma with an epidermal in situ component. These recurrences can be prevented by the removal of 1.0 cm of normal skin around such a melanoma. Microsatellites constitute a risk factor for local recurrence, but are a relatively uncommon phenomenon at tumor thickness less than 3.0 mm.

Entities:  

Mesh:

Year:  1984        PMID: 6508406      PMCID: PMC1250595          DOI: 10.1097/00000658-198412000-00015

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  15 in total

1.  Results of treatment of 269 patients with primary cutaneous melanoma: a five-year prospective study.

Authors:  T K Gupta
Journal:  Ann Surg       Date:  1977-08       Impact factor: 12.969

2.  Narrower margins for clinical stage I malignant melanoma.

Authors:  C L Day; M C Mihm; A J Sober; T B Fitzpatrick; R A Malt
Journal:  N Engl J Med       Date:  1982-02-25       Impact factor: 91.245

3.  Tumor thickness as a guide to surgical management of clinical stage I melanoma patients.

Authors:  C M Balch; T M Murad; S J Soong; A L Ingalls; P C Richards; W A Maddox
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

4.  Optimal size of resection margin for thin cutaneous melanoma.

Authors:  A Breslow; S D Macht
Journal:  Surg Gynecol Obstet       Date:  1977-11

5.  Prognostic significance of the histological features of malignant melanoma.

Authors:  V J McGovern; H M Shaw; G W Milton; G A Farago
Journal:  Histopathology       Date:  1979-09       Impact factor: 5.087

6.  Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat.

Authors:  C L Day; T J Harrist; F Gorstein; A J Sober; R A Lew; R J Friedman; B S Pasternack; A W Kopf; T B Fitzpatrick; M C Mihm
Journal:  Ann Surg       Date:  1981-07       Impact factor: 12.969

7.  Optimal resection margin for cutaneous malignant melanoma.

Authors:  D E Elder; D Guerry; R M Heiberger; D LaRossa; L I Goldman; W H Clark; C J Thompson; I Matozzo; M Van Horn
Journal:  Plast Reconstr Surg       Date:  1983-01       Impact factor: 4.730

8.  Patients' perceptions of the cosmetic impact of melanoma resection.

Authors:  B R Cassileth; E J Lusk; A N Tenaglia
Journal:  Plast Reconstr Surg       Date:  1983-01       Impact factor: 4.730

9.  Aspects of surgical treatment for malignant melanoma: the place of biopsy and wide excision.

Authors:  T T Pitt
Journal:  Aust N Z J Surg       Date:  1977-12

10.  Changes in clinical presentation and management of malignant melanoma.

Authors:  F H Bagley; B Cady; A Lee; M A Legg
Journal:  Cancer       Date:  1981-05-01       Impact factor: 6.860

View more
  8 in total

1.  Limited role for histopathological examination of re-excision specimens of completely excised melanomas.

Authors:  A C de Waal; R Vossen; K K H Aben; L A L M Kiemeney; M M van Rossum; W A M Blokx
Journal:  Virchows Arch       Date:  2014-05-29       Impact factor: 4.064

Review 2.  Treatment strategy for cutaneous malignant melanoma.

Authors:  Arata Tsutsumida; Hiroshi Furukawa; Yuhei Yamamoto; Tsuneki Sugihara
Journal:  Int J Clin Oncol       Date:  2005-10       Impact factor: 3.402

3.  The prognostic significance of microsatellites in cutaneous melanoma.

Authors:  Maarten G Niebling; Lauren E Haydu; Serigne N Lo; Robert V Rawson; Lieke G E Lamboo; Joram T Stollman; Rooshdiya Z Karim; John F Thompson; Richard A Scolyer
Journal:  Mod Pathol       Date:  2020-02-13       Impact factor: 7.842

Review 4.  Surgical management of primary melanoma.

Authors:  D Costello; A Powers; J Lynn; C W Cruse; D Reintgen
Journal:  Curr Oncol Rep       Date:  2000-07       Impact factor: 5.075

5.  Skin mapping with punch biopsies for defining margins in melanoma: when you don't know how far to go.

Authors:  Lynn Dengel; Kristin Turza; Mary-Margaret B Noland; James W Patterson; Craig L Slingluff
Journal:  Ann Surg Oncol       Date:  2008-09-12       Impact factor: 5.344

6.  Malignant melanoma: factors affecting the surgical interval from excision biopsy to definitive surgical management.

Authors:  M R Boland; R S Prichard; G A Bass; Z Al-Hilli; A Levendale; D Gibbons; K Sheahan; B Kirby; E W McDermott; D Evoy
Journal:  Ir J Med Sci       Date:  2014-06-11       Impact factor: 1.568

7.  Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma.

Authors:  Jeffrey P North; Toshiro Kageshita; Daniel Pinkel; Philip E LeBoit; Boris C Bastian
Journal:  J Invest Dermatol       Date:  2008-03-06       Impact factor: 8.551

8.  Role of radiotherapy in melanoma management.

Authors:  Primoz Strojan
Journal:  Radiol Oncol       Date:  2010-03-18       Impact factor: 2.991

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.